Shigematsu T - Search Results

1

Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation.

Yamashita H, Yamazaki Y, Hasegawa H, Yamashita T, Fukumoto S, Shigematsu T, Kazama JJ, Fukagawa M, Noguchi S. Yamashita H, et al. Among authors: shigematsu t. Endocr J. 2007 Jun;54(3):465-70. doi: 10.1507/endocrj.k06-156. Epub 2007 Apr 27. Endocr J. 2007. PMID: 17464094 Free article.

2

[PTH and bone metabolism in chronic dialysis patients].

Fukagawa M, Kazama J, Shigematsu T. Fukagawa M, et al. Among authors: shigematsu t. Rinsho Byori. 2001 Mar;49(3):236-8. Rinsho Byori. 2001. PMID: 11307321 Review. Japanese.

3

Skeletal resistance to pth as a basic abnormality underlying uremic bone diseases.

Fukagawa M, Kazama JJ, Shigematsu T. Fukagawa M, et al. Among authors: shigematsu t. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S152-5. doi: 10.1053/ajkd.2001.27426. Am J Kidney Dis. 2001. PMID: 11576943 Review.

4

Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients.

Nakanishi S, Kazama JJ, Shigematsu T, Iwasaki Y, Cantor TL, Kurosawa T, Fukagawa M. Nakanishi S, et al. Among authors: shigematsu t. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S172-4. doi: 10.1053/ajkd.2001.27436. Am J Kidney Dis. 2001. PMID: 11576948 Clinical Trial.

5

Osteoprotegerin levels before and after renal transplantation.

Sato T, Tominaga Y, Iwasaki Y, Kazama JJ, Shigematsu T, Inagaki H, Watanabe I, Katayama A, Haba T, Uchida K, Fukagawa M. Sato T, et al. Among authors: shigematsu t. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S175-7. doi: 10.1053/ajkd.2001.27437. Am J Kidney Dis. 2001. PMID: 11576949 Clinical Trial.

6

Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure.

Kazama JJ, Shigematsu T, Yano K, Tsuda E, Miura M, Iwasaki Y, Kawaguchi Y, Gejyo F, Kurokawa K, Fukagawa M. Kazama JJ, et al. Among authors: shigematsu t. Am J Kidney Dis. 2002 Mar;39(3):525-32. doi: 10.1053/ajkd.2002.31402. Am J Kidney Dis. 2002. PMID: 11877571

7

The negative Ca(2+) balance is involved in the stimulation of PTH secretion.

Yokoyama K, Kagami S, Ohkido I, Kato N, Yamamoto H, Shigematsu T, Nakayama M, Fukagawa M, Kawaguchi Y, Hosoya T. Yokoyama K, et al. Among authors: shigematsu t. Nephron. 2002 Sep;92(1):86-90. doi: 10.1159/000064484. Nephron. 2002. PMID: 12187089

8

Management of patients with advanced secondary hyperparathyroidism: the Japanese approach.

Fukagawa M, Kazama JJ, Shigematsu T. Fukagawa M, et al. Among authors: shigematsu t. Nephrol Dial Transplant. 2002 Sep;17(9):1553-7. doi: 10.1093/ndt/17.9.1553. Nephrol Dial Transplant. 2002. PMID: 12198204 Review. No abstract available.

9

Circulating osteoprotegerin is not removed through haemodialysis membrane.

Kazama JJ, Kato H, Sato T, Shigematsu T, Fukagawa M, Iwasaki Y, Gejyo F. Kazama JJ, et al. Among authors: shigematsu t. Nephrol Dial Transplant. 2002 Oct;17(10):1860-1. doi: 10.1093/ndt/17.10.1860. Nephrol Dial Transplant. 2002. PMID: 12271009 No abstract available.

10

IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker.

Tanno Y, Yokoyama K, Nakayama M, Katoh A, Yamamoto H, Iwasaki Y, Cantor T, Fukagawa M, Shigematsu T, Hosoya T. Tanno Y, et al. Among authors: shigematsu t. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii97-8. doi: 10.1093/ndt/gfg1025. Nephrol Dial Transplant. 2003. PMID: 12771313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters